322P Ivosidenib in pretreated Japanese (JPN) patients (pts) with mutant isocitrate dehydrogenase 1 (mIDH1) nonresectable/metastatic cholangiocarcinoma (n/mCCA): Phase II study results
Title:
322P Ivosidenib in pretreated Japanese (JPN) patients (pts) with mutant isocitrate dehydrogenase 1 (mIDH1) nonresectable/metastatic cholangiocarcinoma (n/mCCA): Phase II study results
Author:
Satake, T. Maruki, Y. Ikezawa, K. Komatsu, Y. Tanaka, Y. Asagi, A. Suzuki, T. Li, A. Simonot, L. Ueno, M.